Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Commun Biol ; 7(1): 654, 2024 May 28.
Artículo en Inglés | MEDLINE | ID: mdl-38806677

RESUMEN

SMG9 is an essential component of the nonsense-mediated mRNA decay (NMD) machinery, a quality control mechanism that selectively degrades aberrant transcripts. Mutations in SMG9 are associated with heart and brain malformation syndrome (HBMS). However, the molecular mechanism underlying HBMS remains unclear. We generated smg9 mutant zebrafish (smg9oi7/oi7) that have a lifespan of approximately 6 months or longer, allowing for analysis of the in vivo function of Smg9 in adults in more detail. smg9oi7/oi7 zebrafish display congenital brain abnormalities and reduced cardiac contraction. Additionally, smg9oi7/oi7 zebrafish exhibit a premature aging phenotype. Analysis of NMD target mRNAs shows a trend toward increased mRNA levels in smg9oi7/oi7 zebrafish. Spermidine oxidase (Smox) is increased in smg9oi7/oi7 zebrafish, resulting in the accumulation of byproducts, reactive oxygen species, and acrolein. The accumulation of smox mRNA due to NMD dysregulation caused by Smg9 deficiency leads to increased oxidative stress, resulting in premature aging.


Asunto(s)
Envejecimiento Prematuro , Degradación de ARNm Mediada por Codón sin Sentido , Proteínas de Pez Cebra , Pez Cebra , Animales , Pez Cebra/genética , Envejecimiento Prematuro/genética , Proteínas de Pez Cebra/genética , Proteínas de Pez Cebra/metabolismo , Proteínas de Pez Cebra/deficiencia , ARN Mensajero/genética , ARN Mensajero/metabolismo , Estrés Oxidativo , Mutación
2.
Biochem Biophys Res Commun ; 699: 149551, 2024 Mar 05.
Artículo en Inglés | MEDLINE | ID: mdl-38277730

RESUMEN

V-ATPase is an ATP hydrolysis-driven proton pump involved in the acidification of intracellular organelles and systemic acid-base homeostasis through H+ secretion in the renal collecting ducts. V-ATPase dysfunction is associated with hereditary distal renal tubular acidosis (dRTA). ATP6V1B1 encodes the B1 subunit of V-ATPase that is integral to ATP hydrolysis and subsequent H+ transport. Patients with pathogenic ATP6V1B1 mutations often exhibit an early onset of sensorineural hearing loss. However, the mechanisms underlying this association remain unclear. We employed morpholino oligonucleotide-mediated knockdown and CRISPR/Cas9 gene editing to generate Atp6v1ba-deficient (atp6v1ba-/-) zebrafish as an ortholog model for ATP6V1B1. The atp6v1ba-/- zebrafish exhibited systemic acidosis and significantly smaller otoliths compared to wild-type siblings. Moreover, deficiency in Atp6v1ba led to degeneration of inner ear hair cells, with ultrastructural changes indicative of autophagy. Our findings indicate a critical role of ATP6V1B1 in regulating lysosomal pH and autophagy in hair cells, and the results provide insights into the pathophysiology of sensorineural hearing loss in dRTA. Furthermore, this study demonstrates that the atp6v1ba-/- zebrafish model is a valuable tool for further investigation into disease mechanisms and potential therapies for acidosis-related hearing impairment.


Asunto(s)
Acidosis Tubular Renal , Acidosis , Pérdida Auditiva Sensorineural , Compuestos Organometálicos , ATPasas de Translocación de Protón Vacuolares , Animales , Humanos , Pez Cebra/metabolismo , ATPasas de Translocación de Protón Vacuolares/genética , ATPasas de Translocación de Protón Vacuolares/metabolismo , Pérdida Auditiva Sensorineural/genética , Pérdida Auditiva Sensorineural/patología , Mutación , Acidosis Tubular Renal/genética , Células Ciliadas Auditivas/patología , Concentración de Iones de Hidrógeno , Cabello/metabolismo , Adenosina Trifosfato
3.
CEN Case Rep ; 11(4): 506-510, 2022 11.
Artículo en Inglés | MEDLINE | ID: mdl-35596114

RESUMEN

Rituximab (RTX) has been used to treat B cell lineage lymphoma/leukemia or autoimmune or autoinflammatory disorders. RTX therapy has been extensively applied to cases of frequently relapsing nephrotic syndrome (FRNS) and steroid-dependent nephrotic syndrome. Rituximab-induced serum sickness (RISS) has been recognized as a rare severe type-3 hypersensitivity reaction in patients treated with RTX. We herein report a 10-year-old girl with RISS in FRNS. She was diagnosed with RISS based on characteristic symptoms, such as a fever, rash, arthritis, or proteinuria, during RTX therapy associated with a high level of human anti-chimeric antibody. Even after recovering from acute symptoms by RISS, she suffered from worsening relapses of nephrotic syndrome. The symptoms of RISS are non-specific, resembling viral infections, autoinflammatory diseases and Kawasaki disease, especially in children. While RISS is a rare complication among patients with nephrotic syndrome, it should be carefully considered as a severe complication in patients being treated with RTX.


Asunto(s)
Síndrome Nefrótico , Enfermedad del Suero , Niño , Femenino , Humanos , Rituximab , Síndrome Nefrótico/diagnóstico , Enfermedad del Suero/inducido químicamente , Factores Inmunológicos , Recurrencia
5.
Nutrients ; 13(9)2021 Aug 29.
Artículo en Inglés | MEDLINE | ID: mdl-34578904

RESUMEN

The liver function is essential for metabolism, detoxification, and bile synthesis, even in the neonatal period. Autophagy plays significance roles in THE adult liver, whereas the role of liver autophagy in the early neonatal period largely remains unclear. To clarify the importance of liver autophagy in the neonatal starvation period, we generated liver-specific autophagy-deficient (Atg5flox/flox; Albumin-Cre) mice and investigated under starvation conditions comparing with control (Atg5flox/+; Albumin-Cre) mice, focusing on serum metabolites and liver histopathology. As a result, autophagy in the liver was found to unessential for the survival under postnatal starvation. A metabolomics analysis of serum metabolites by gas chromatography-tandem mass spectrometry showed a significant difference between the groups, especially after 12-h starvation, suggesting the synergistical adaption of metabolic pathways, such as the "malate-aspartate shuttle", "aspartate metabolism", "urea cycle", and "glycine and serine metabolism". Liver-specific autophagy-deficiency under postnatal starvation conditions can cause a characteristic metabolic alteration suggesting a change of the mitochondrial function. Neonates seemed to maintain ketone production under starvation conditions, even in the autophagy-deficient liver, through a change in the mitochondrial function, which may be an adaptive mechanism for avoiding fatal starvation.


Asunto(s)
Proteína 5 Relacionada con la Autofagia/deficiencia , Autofagia , Hígado/metabolismo , Metaboloma , Inanición/sangre , Animales , Animales Recién Nacidos , Cromatografía de Gases y Espectrometría de Masas , Ratones
6.
Sci Rep ; 11(1): 8392, 2021 04 16.
Artículo en Inglés | MEDLINE | ID: mdl-33863987

RESUMEN

Leucyl-tRNA synthetase (LARS) is an enzyme that catalyses the ligation of leucine with leucine tRNA. LARS is also essential to sensitize the intracellular leucine concentration to the mammalian target of rapamycin complex 1 (mTORC1) activation. Biallelic mutation in the LARS gene causes infantile liver failure syndrome type 1 (ILFS1), which is characterized by acute liver failure, anaemia, and neurological disorders, including microcephaly and seizures. However, the molecular mechanism underlying ILFS1 under LARS deficiency has been elusive. Here, we generated Lars deficient (larsb-/-) zebrafish that showed progressive liver failure and anaemia, resulting in early lethality within 12 days post fertilization. The atg5-morpholino knockdown and bafilomycin treatment partially improved the size of the liver and survival rate in larsb-/- zebrafish. These findings indicate the involvement of autophagy in the pathogenesis of larsb-/- zebrafish. Indeed, excessive autophagy activation was observed in larsb-/- zebrafish. Therefore, our data clarify a mechanistic link between LARS and autophagy in vivo. Furthermore, autophagy regulation by LARS could lead to development of new therapeutics for IFLS1.


Asunto(s)
Anemia/patología , Autofagia , Leucina-ARNt Ligasa/deficiencia , Leucina/metabolismo , Fallo Hepático/patología , Pez Cebra/crecimiento & desarrollo , Anemia/enzimología , Anemia/etiología , Animales , Fallo Hepático/enzimología , Fallo Hepático/etiología , Pez Cebra/metabolismo
7.
CEN Case Rep ; 10(2): 241-243, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33159669

RESUMEN

HDR syndrome is characterized by the triad of primary hypoparathyroidism, sensorineural hearing loss and renal malformation with widely variable manifestations. It is an autosomal dominant inherited disease caused by a mutation of the GATA3 (NM_001002295.2), which is located on chromosome 10p14. Congenital heart disease, such as tetralogy of Fallot, a typical complication of DiGeorge syndrome, is a rare complication of HDR syndrome. We herein report a case of HDR syndrome coexisting tetralogy of Fallot with a novel mutation, c.964C > T (p.Gln322*). This case suggested that the screening of renal involvement should be carefully performed in patients with a phenotypic combination of hypoparathyroidism and sensorineural hearing loss, to facilitate the early diagnosis of HDR syndrome. In addition, when the deletion of chromosome 22q11.2 is not detected by a fluorescence in situ hybridization analysis in patients exhibiting the partial phenotype of DiGeorge syndrome, the possibility of HDR syndrome should be considered and the renal function should be repeatedly evaluated.


Asunto(s)
Pérdida Auditiva Sensorineural/diagnóstico , Hipoparatiroidismo/diagnóstico , Nefrosis/diagnóstico , Absceso/etiología , Factor de Transcripción GATA3/genética , Pérdida Auditiva Sensorineural/complicaciones , Humanos , Hipoparatiroidismo/complicaciones , Enfermedades Renales/etiología , Mutación , Nefrosis/complicaciones , Tetralogía de Fallot/complicaciones
8.
Eur J Med Genet ; 61(10): 631-633, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29673649

RESUMEN

22q13 deletion syndrome is a genetic disorder caused by the deletion or disruption of the segment of the long arm of chromosome 22. The characteristic clinical features of this syndrome include delayed expressive speech, autistic behavior and hypotonia, and clinically severe complications associated with autoimmunity are rarely reported. We herein report a girl with 22q13 deletion syndrome complicated with multiple inflammatory and autoimmune diseases during early childhood. We performed whole-exome sequencing to identify the genes responsible for her autoimmune diseases and identified the de novo variant p.R512W in the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta (PIK3CD) gene. We suspected it to be the disease-causing variant at the conserved residue in PIK(3)C p110δ. Alternatively, haplo-insufficiency of SHANK3 or other genes by 22q13 deletion and the PIK3CD variant might have synergistically contributed to the onset of the distinctive clinical manifestations in this patient.


Asunto(s)
Enfermedades Autoinmunes/genética , Trastornos de los Cromosomas/genética , Fosfatidilinositol 3-Quinasa Clase I/genética , Enfermedades Autoinmunes/diagnóstico , Deleción Cromosómica , Trastornos de los Cromosomas/diagnóstico , Trastornos de los Cromosomas/inmunología , Cromosomas Humanos Par 22/genética , Cromosomas Humanos Par 22/inmunología , Femenino , Humanos , Lactante , Mutación
9.
Am J Med Genet A ; 161A(10): 2600-3, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23950000

RESUMEN

A male infant, born at 32 weeks gestation by cesarean because of hydrops fetalis, presented with multiple anomalies, such as sparse and curly scalp hair, absent eyebrows, frontal bossing, an atrial septal defect, pulmonary artery stenosis, and whole myocardial thickening. He was clinically diagnosed with cardio-facio-cutaneous (CFC) syndrome, and was confirmed to have a germline V-raf murine sarcoma viral oncogene homologue B1 (BRAF) c.721 A>C mutation. At 1 month of age, he presented with a transient myelodysplastic/myeloproliferative neoplasm (MDS/MPN), which improved within a month without the administration of antineoplastic agents. This is the first report of CFC syndrome with MDS/MPN. The coexistence of MDS/MPN may be related to this BRAF c.721 A>C mutation.


Asunto(s)
Síndrome de Down/complicaciones , Displasia Ectodérmica/complicaciones , Displasia Ectodérmica/genética , Insuficiencia de Crecimiento/complicaciones , Insuficiencia de Crecimiento/genética , Mutación de Línea Germinal , Cardiopatías Congénitas/complicaciones , Cardiopatías Congénitas/genética , Reacción Leucemoide/complicaciones , Proteínas Proto-Oncogénicas B-raf/genética , Sustitución de Aminoácidos , Codón , Síndrome de Down/diagnóstico , Displasia Ectodérmica/diagnóstico , Facies , Insuficiencia de Crecimiento/diagnóstico , Genotipo , Cardiopatías Congénitas/diagnóstico , Humanos , Recién Nacido , Reacción Leucemoide/diagnóstico , Masculino , Fenotipo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...